|
1. Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531-8. 2. World Health Organization. World Health Organization (WHO) Coronavirus (COVID-19) Dashboard (2022). World Health Organization, URL: https://covid19. who. int/. (Accessed: 28 February 2022). 2022. 3. Samsami M, Mehravaran E, Tabarsi P, Javadi A, Arsang-Jang S, Komaki A, et al. Clinical and demographic characteristics of patients with COVID-19 infection: statistics from a single hospital in Iran. Hum Antibodies. 2021;29(1):49-54. 4. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P. A novel coronavirus from patients with pneumonia in China, 2019. NEJM. 2020 Jan 24. 5. Goshayeshi L, Rad MA, Bergquist R, Allahyari A, Hashemzadeh K, Milani N, Gholian-Aval M, Rezaeitalab F, Quchani MJ, Nahbandani Z, Javid Z. Demographic and clinical characteristics of the severe Covid-19 infections: first report from Mashhad University of Medical Sciences, Iran. medRxiv. 2020 May 23:2020-05. 6. Cochrane COVID-19 Diagnostic Test Accuracy Group. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. CDSR. 2022 May 20;2022(5):CD013665. 7. Alsofayan YM, Althunayyan SM, Khan AA, Hakawi AM, Assiri AM. Clinical characteristics of COVID-19 in Saudi Arabia: a national retrospective study. J. Infect. Public Health. 2020 Jul 1;13(7):920-5. 8. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. lancet. 2020 Feb 15;395(10223):497-506. 9. Ssentongo P, Ssentongo AE, Heilbrunn ES, Ba DM, Chinchilli VM. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis. PloS one. 2020 Aug 26;15(8):e0238215. 10. Chen T, Wu DI, Chen H, Yan W, Yang D, Chen G, Ma K, Xu D, Yu H, Wang H, Wang T. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. bmj. 2020 Mar 26;368. 11. Jalili M, Payandemehr P, Saghaei A, Sari HN, Safikhani H, Kolivand P. Characteristics and mortality of hospitalized patients with COVID-19 in Iran: a national retrospective cohort study. Ann Intern Med. 2021 Jan;174(1):125-7. 12. Salari A, Mahdavi-Roshan M, Ghorbani Z, Mortazavi SS, Naghshbandi M, Faraghnia F, Rahbar Taramsari M, Ahmadnia Z. An investigation of risk factors of in-hospital death due to COVID-19: a case-control study in Rasht, Iran. Ir J Med Sci (1971-). 1971:1-3. 13. Martins-Filho PR, Tavares CS, Santos VS. Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data. Eur J Intern Med. 2020 Jun 1;76:97-9. 14. Polverino F, Stern DA, Ruocco G, Balestro E, Bassetti M, Candelli M, Cirillo B, Contoli M, Corsico A, D'Amico F, D'Elia E. Comorbidities, cardiovascular therapies, and COVID-19 mortality: a nationwide, Italian Observational Study (ItaliCO). Front Cardiovasc Med. 2020 Oct 9;7:585866. 15. Ferrando C, Suarez-Sipmann F, Mellado-Artigas R, Hernández M, Gea A, Arruti E, et al. Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Med. 2020;46(12):2200-11. 16. Alamdari NM, Afaghi S, Rahimi FS, Tarki FE, Tavana S, Zali A, et al. Mortality risk factors among hospitalized COVID-19 patients in a major referral center in Iran. Tohoku J Exp Med. 2020;252(1):73-84. 17. Cheng A, Hu L, Wang Y, Huang L, Zhao L, Zhang C, et al. Diagnostic performance of initial blood urea nitrogen combined with D-dimer levels for predicting in-hospital mortality in COVID-19 patients. Int J Antimicrob Agents. 2020;56(3):106110. 18. Hasan SS, Capstick T, Ahmed R, Kow CS, Mazhar F, Merchant HA, et al. Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis. Expert Rev Respir Med. 2020;14(11):1149-63. 19. Abdollahi A, Kamali Sarvestani H, Rafat Z, Ghaderkhani S, Mahmoudi‐Aliabadi M, Jafarzadeh B, et al. The association between the level of serum 25 (OH) vitamin D, obesity, and underlying diseases with the risk of developing COVID‐19 infection: A case-control study of hospitalized patients in Tehran, Iran. J Med Virol. 2021;93(4):2359-64. 20. Wiener-Kronish JP, Cohen NH, Leslie K, Gropper MA, Eriksson LI, Fleisher LA, editors. Miller's anesthesia, 2-volume set E-book. Elsevier Health Sciences; 2019 Oct 7. 21. Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika. 1965 Dec 1;52(3/4):591-611. 22. Rosner B. Fundamentals of biostatistics: Cengage learning; 2015. 23. Bonanad C, García-Blas S, Tarazona-Santabalbina F, Sanchis J, Bertomeu-González V, Fácila L, et al. The effect of age on mortality in patients with COVID-19: a meta-analysis with 611,583 subjects. JAMDA. 2020;21(7):915-8. 24. Zali A, Gholamzadeh S, Mohammadi G, Looha MA, Akrami F, Zarean E, Vafaee R, Maher A, Khodadoost M. Baseline characteristics and associated factors of mortality in COVID-19 patients; an analysis of 16000 cases in Tehran, Iran. AAEM. 2020;8(1). 25. Bhopal SS, Bhopal R. Sex differential in COVID-19 mortality varies markedly by age. Lancet. 2020 Aug 22;396(10250):532-3. 26. Jin J-M, Bai P, He W, Wu F, Liu X-F, Han D-M, et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020;8:152. 27. Krieger N, Chen JT, Waterman PD. Excess mortality in men and women in Massachusetts during the COVID-19 pandemic. Lancet. 2020;395(10240):1829. 28. Clark A, Jit M, Warren-Gash C, Guthrie B, Wang HH, Mercer SW, et al. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Lancet Glob Health. 2020;8(8):e1003-e17. 29. Najera H, Ortega-Avila AG. Health and Institutional Risk Factors of COVID-19 Mortality in Mexico, 2020. Am J Prev Med. 2021;60(4):471-7. 30. Mirjalili M, Dehghani M, Raadabadi M, Dehghani A. Death risk among COVID-19 patients in Yazd, Iran: a hospital-based case-cohort study. Journal Mil Med. 2021;23(3):274-82. 31. Tzotzos SJ, Fischer B, Fischer H, Zeitlinger M. Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey. J Crit Care. 2020;24(1):1-4. 32. Fan E, Beitler JR, Brochard L, Calfee CS, Ferguson ND, Slutsky AS, Brodie D. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?. Lancet Respir Med. 2020 Aug 1;8(8):816-21. 33. Hsu C-Y, Lai C-C, Yeh Y-P, Chang-Chuan C, Chen H-H. Progression from Pneumonia to ARDS as a Predictor for Fatal COVID-19. J Infect Public Health. 2021;14(4):504-7. 34. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Jama. 2020;323(11):1061-9. 35. Gallo Marin B, Aghagoli G, Lavine K, Yang L, Siff EJ, Chiang SS, et al. Predictors of COVID‐19 severity: a literature review. Rev Med Virol. 2021;31(1):1-10.
|
